ELIMITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Elimite, and when can generic versions of Elimite launch?
Elimite is a drug marketed by Aurobindo Pharma Usa and is included in one NDA.
The generic ingredient in ELIMITE is permethrin. There are five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the permethrin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Elimite
A generic version of ELIMITE was approved as permethrin by ACTAVIS LABS on January 23rd, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ELIMITE?
- What are the global sales for ELIMITE?
- What is Average Wholesale Price for ELIMITE?
Summary for ELIMITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 97 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,192 |
| Drug Prices: | Drug price information for ELIMITE |
| What excipients (inactive ingredients) are in ELIMITE? | ELIMITE excipients list |
| DailyMed Link: | ELIMITE at DailyMed |
Recent Clinical Trials for ELIMITE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Saptalis Pharmaceuticals | Phase 3 |
| Saptalis Pharmaceuticals LLC | Phase 3 |
| Encube Ethicals Pvt. Ltd. | Phase 3 |
Pharmacology for ELIMITE
| Drug Class | Pyrethroid |
US Patents and Regulatory Information for ELIMITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | ELIMITE | permethrin | CREAM;TOPICAL | 019855-001 | Aug 25, 1989 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
